Common Contracts
3 similar Sharing and Cooperation Agreement contracts by Dermavant Sciences LTD, Immunovant, Inc., Urovant Sciences Ltd.
AMENDED AND RESTATED INFORMATION SHARING AND COOPERATION AGREEMENT by and among IMMUNOVANT SCIENCES LTD. AND ROIVANT SCIENCES LTD. Dated as of December 28, 2018Sharing and Cooperation Agreement • December 20th, 2019 • Immunovant, Inc. • Blank checks • New York
This AMENDED AND RESTATED INFORMATION SHARING AND COOPERATION AGREEMENT (this “Agreement”), dated as of December 28, 2018 (the “Effective Date”), is entered into by and among Immunovant Sciences Ltd., a Bermuda exempted limited company (the “Company”), Roivant Sciences Ltd., a Bermuda exempted limited company (“Roivant”), and the Persons who from time to time become Shareholders of the Company in accordance with this Agreement and execute and deliver a Joinder Agreement, substantially as set forth on Exhibit A (a “Joinder Agreement”), (with each of the Company, Roivant and such Persons, individually, a “Party” and together, the “Parties”).
AMENDED AND RESTATED INFORMATION SHARING AND COOPERATION AGREEMENT by and among DERMAVANT SCIENCES LTD. AND ROIVANT SCIENCES LTD. Dated as of June 7, 2019Sharing and Cooperation Agreement • June 10th, 2019 • Dermavant Sciences LTD • Pharmaceutical preparations • New York
This AMENDED AND RESTATED INFORMATION SHARING AND COOPERATION AGREEMENT (this “Agreement”), dated as of June 7, 2019 (the “Effective Date”), is entered into by and among Dermavant Sciences Ltd., a Bermuda exempted limited company (the “Company”), Roivant Sciences Ltd., a Bermuda exempted limited company (“Roivant”), (with each of the Company and Roivant a “Party” and together, the “Parties”).
INFORMATION SHARING AND COOPERATION AGREEMENT by and among UROVANT SCIENCES LTD., AND ROIVANT SCIENCES LTD. Dated as of July 9, 2018Sharing and Cooperation Agreement • July 13th, 2018 • Urovant Sciences Ltd. • Pharmaceutical preparations • New York
This INFORMATION SHARING AND COOPERATION AGREEMENT (this “Agreement”), dated as of July 9, 2018 (the “Effective Date”), is entered into between Urovant Sciences Ltd., a Bermuda exempted limited company (the “Company”) and Roivant Sciences Ltd., a Bermuda exempted limited company (“Roivant”), (with each of the Company and Roivant, a “Party” and together, the “Parties”).
